We are on the cusp of a new dawn for CUP patients. Research has led to new capabilities for identifying the tissue of origin of the cancer through molecular testing; and we are beginning to see the potential for finding actionable molecular targets from DNA mutations where the primary site is largely irrelevant. Our international conference in London in MayRead more
Category Supporters